{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T18:02:41Z","timestamp":1787680961680,"version":"build-2784847793"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008920","name":"University of Saskatchewan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008920","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.bioorg.2025.108698","type":"journal-article","created":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T18:55:17Z","timestamp":1750359317000},"page":"108698","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Discovery of reversible monoacylglycerol lipase (MAGL) inhibitors based on ortho-hydroxyanilide scaffold"],"prefix":"10.1016","volume":"163","author":[{"given":"Giulia","family":"Bononi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Gado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuele","family":"Masoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Scalabrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larissa Della","family":"Vedova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriana","family":"Di Stefano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Piazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarissa","family":"Poles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Lonzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Landucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Vagaggini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Poggialini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalaura","family":"Brai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Caligiuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavio","family":"Rizzolio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kawthar A.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Bertini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ersilia","family":"De Lorenzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Dreassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Macchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Minutolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert B.","family":"Laprairie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlotta","family":"Granchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziano","family":"Tuccinardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.bioorg.2025.108698_bb0005","first-page":"607","article-title":"Review of the endocannabinoid system","volume":"6","author":"Lu","year":"2021","journal-title":"Biol. Psychiatry. Cogn. Neurosci. Neuroimaging."},{"issue":"5","key":"10.1016\/j.bioorg.2025.108698_bb0010","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/nrd2553","article-title":"Targeting the endocannabinoid system: to enhance or reduce?","volume":"7","author":"Di Marzo","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"issue":"2\u20133","key":"10.1016\/j.bioorg.2025.108698_bb0015","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1054\/plef.2001.0341","article-title":"Cannabinoid receptors and their ligands","volume":"66","author":"Pertwee","year":"2002","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"issue":"12","key":"10.1016\/j.bioorg.2025.108698_bb0020","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.chembiol.2007.11.006","article-title":"A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-Arachidonoylglycerol","volume":"14","author":"Blankman","year":"2007","journal-title":"Chem. Biol."},{"issue":"17","key":"10.1016\/j.bioorg.2025.108698_bb0025","doi-asserted-by":"crossref","first-page":"9472","DOI":"10.3390\/ijms22179472","article-title":"The endocannabinoid system: a potential target for the treatment of various diseases","volume":"22","author":"Lowe","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108698_bb0030","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/phar.1187","article-title":"The pharmacologic and clinical effects of medical Cannabis","volume":"33","author":"Borgelt","year":"2013","journal-title":"Pharmacother. J. Hum. Pharmacol. Drug Ther."},{"key":"10.1016\/j.bioorg.2025.108698_bb0035","first-page":"8","article-title":"Targeting cannabinoid signaling in the immune system: \u201chigh\u201d-ly exciting questions, possibilities, and challenges","author":"Ol\u00e1h","year":"2017","journal-title":"Front. Immunol."},{"issue":"71","key":"10.1016\/j.bioorg.2025.108698_bb0040","first-page":"1","article-title":"2-Arachidonoylglycerol: a signaling lipid with manifold actions in the brain","volume":"2018","author":"Baggelaar","year":"2017","journal-title":"Prog. Lipid Res."},{"issue":"6057","key":"10.1016\/j.bioorg.2025.108698_bb0045","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1126\/science.1209200","article-title":"Endocannabinoid hydrolysis generates brain prostaglandins that promote Neuroinflammation","volume":"334","author":"Nomura","year":"2011","journal-title":"Science"},{"issue":"July","key":"10.1016\/j.bioorg.2025.108698_bb0050","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.bcp.2018.07.036","article-title":"Monoacylglycerol lipase (MAGL) as a promising therapeutic target","volume":"157","author":"Gil-Ord\u00f3\u00f1ez","year":"2018","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108698_bb0055","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1460-9568.2004.03428.x","article-title":"Segregation of two endocannabinoid-hydrolyzing enzymes into pre- and postsynaptic compartments in the rat hippocampus, cerebellum and amygdala","volume":"20","author":"Gulyas","year":"2004","journal-title":"Eur. J. Neurosci."},{"issue":"16","key":"10.1016\/j.bioorg.2025.108698_bb0060","doi-asserted-by":"crossref","first-page":"10819","DOI":"10.1073\/pnas.152334899","article-title":"Brain monoglyceride lipase participating in endocannabinoid inactivation","volume":"99","author":"Dinh","year":"2002","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108698_bb0065","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.apsb.2019.10.006","article-title":"Monoacylglycerol lipase inhibitors: modulators for lipid metabolism in cancer malignancy, neurological and metabolic disorders","volume":"10","author":"Deng","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"issue":"8\u20139","key":"10.1016\/j.bioorg.2025.108698_bb0070","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.lfs.2012.10.025","article-title":"Therapeutic potential of monoacylglycerol lipase inhibitors","volume":"92","author":"Mulvihill","year":"2013","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108698_bb0075","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cell.2009.11.027","article-title":"Monoacylglycerol lipase regulates a fatty acid network that promotes Cancer pathogenesis","volume":"140","author":"Nomura","year":"2010","journal-title":"Cell"},{"issue":"36","key":"10.1016\/j.bioorg.2025.108698_bb0080","doi-asserted-by":"crossref","first-page":"24874","DOI":"10.1074\/jbc.M114.581785","article-title":"Arachidonic acid induces direct interaction of the p67 -Rac complex with the phagocyte oxidase Nox2, leading to superoxide production","volume":"289","author":"Matono","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2025.108698_bb0085","doi-asserted-by":"crossref","first-page":"C960","DOI":"10.1152\/ajpcell.00251.2015","article-title":"Oxyradical stress increases the biosynthesis of 2-arachidonoylglycerol: involvement of NADPH oxidase","volume":"311","author":"Matthews","year":"2016","journal-title":"Am. J. Physiol. Physiol."},{"issue":"6","key":"10.1016\/j.bioorg.2025.108698_bb0090","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1007\/s12035-022-02800-y","article-title":"Inflammation and nitro-oxidative stress as drivers of endocannabinoid system aberrations in mood disorders and schizophrenia","volume":"59","author":"Morris","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bioorg.2025.108698_bb0095","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.freeradbiomed.2023.07.019","article-title":"MAGL inhibition relieves synovial inflammation and pain via regulating NOX4-Nrf2 redox balance in osteoarthritis","volume":"208","author":"Li","year":"2023","journal-title":"Free Radic. Biol. Med."},{"issue":"7","key":"10.1016\/j.bioorg.2025.108698_bb0100","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1177\/0960327120984220","article-title":"JZL184 protects hippocampal neurons from oxygen-glucose deprivation-induced injury via activating Nrf2\/ARE signaling pathway","volume":"40","author":"Xu","year":"2021","journal-title":"Hum. Exp. Toxicol."},{"issue":"6","key":"10.1016\/j.bioorg.2025.108698_bb0105","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.447","article-title":"Inhibition of MAGL activates the Keap1\/Nrf2 pathway to attenuate glucocorticoid-induced osteonecrosis of the femoral head","volume":"11","author":"Yang","year":"2021","journal-title":"Clin. Transl. Med."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108698_bb0110","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s11033-022-08052-2","article-title":"NRF2 modulation in TRAMP mice: an in vivo model of prostate cancer","volume":"50","author":"Marzioni","year":"2023","journal-title":"Mol. Biol. Rep."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108698_bb0115","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1476-4598-13-20","article-title":"Oncogenic transformation of mesenchymal stem cells decreases Nrf2 expression favoring in vivo tumor growth and poorer survival","volume":"13","author":"Funes","year":"2014","journal-title":"Mol. Cancer"},{"issue":"6","key":"10.1016\/j.bioorg.2025.108698_bb0120","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1258\/ebm.2011.011028","article-title":"Role of nuclear factor- \u03ba B-mediated inflammatory pathways in cancer-related symptoms and their regulation by nutritional agents","volume":"236","author":"Gupta","year":"2011","journal-title":"Exp. Biol. Med."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108698_bb0125","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.3390\/molecules28031356","article-title":"Targeting Nrf2 and NF-\u03baB signaling pathways in Cancer prevention: the role of apple phytochemicals","volume":"28","author":"Gado","year":"2023","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.bioorg.2025.108698_bb0130","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.drudis.2019.10.004","article-title":"Regulating membrane lipid levels at the synapse by small-molecule inhibitors of monoacylglycerol lipase: new developments in therapeutic and PET imaging applications","volume":"25","author":"Grimsey","year":"2020","journal-title":"Drug Discov. Today"},{"issue":"9","key":"10.1016\/j.bioorg.2025.108698_bb0135","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/nn.2616","article-title":"Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system","volume":"13","author":"Schlosburg","year":"2010","journal-title":"Nat. Neurosci."},{"issue":"6","key":"10.1016\/j.bioorg.2025.108698_bb0140","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1124\/mol.110.068304","article-title":"Monoacylglycerol lipase activity is a critical modulator of the tone and integrity of the endocannabinoid system","volume":"78","author":"Chanda","year":"2010","journal-title":"Mol. Pharmacol."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108698_bb0145","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1124\/jpet.114.212753","article-title":"Prolonged monoacylglycerol lipase blockade causes equivalent cannabinoid receptor type 1 receptor\u2013mediated adaptations in fatty acid amide hydrolase wild-type and knockout mice","volume":"350","author":"Schlosburg","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108698_bb0150","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nchembio.129","article-title":"Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects","volume":"5","author":"Long","year":"2009","journal-title":"Nat. Chem. Biol."},{"issue":"20","key":"10.1016\/j.bioorg.2025.108698_bb0155","doi-asserted-by":"crossref","first-page":"9062","DOI":"10.1021\/acs.jmedchem.8b00951","article-title":"Identification of ABX-1431, a selective inhibitor of Monoacylglycerol lipase and clinical candidate for treatment of neurological disorders","volume":"61","author":"Cisar","year":"2018","journal-title":"J. Med. Chem."},{"issue":"10","key":"10.1016\/j.bioorg.2025.108698_bb0160","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.chembiol.2009.09.012","article-title":"Discovery of potent and reversible Monoacylglycerol lipase inhibitors","volume":"16","author":"King","year":"2009","journal-title":"Chem. Biol."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108698_bb0165","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/pro.596","article-title":"Crystal structure of a soluble form of human monoglyceride lipase in complex with an inhibitor at 1.35 \u00c5 resolution","volume":"20","author":"Schalk-Hihi","year":"2011","journal-title":"Protein Sci."},{"issue":"50","key":"10.1016\/j.bioorg.2025.108698_bb0170","doi-asserted-by":"crossref","first-page":"13765","DOI":"10.1002\/anie.201407807","article-title":"A reversible and selective inhibitor of monoacylglycerol lipase ameliorates multiple sclerosis","volume":"53","author":"Hern\u00e1ndez-Torres","year":"2014","journal-title":"Angew. Chem. Int. Ed."},{"issue":"20","key":"10.1016\/j.bioorg.2025.108698_bb0175","doi-asserted-by":"crossref","first-page":"9205","DOI":"10.1021\/acs.jmedchem.8b00824","article-title":"Design, synthesis, and evaluation of Piperazinyl Pyrrolidin-2-ones as a novel series of reversible Monoacylglycerol lipase inhibitors","volume":"61","author":"Aida","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108698_bb0180","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.ejmech.2018.08.038","article-title":"Discovery of long-chain salicylketoxime derivatives as monoacylglycerol lipase (MAGL) inhibitors","volume":"157","author":"Bononi","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108698_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113679","article-title":"Monoacylglycerol lipase (MAGL) inhibitors based on a diphenylsulfide-benzoylpiperidine scaffold","volume":"223","author":"Bononi","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108698_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115916","article-title":"Design, synthesis, ADME and biological evaluation of benzylpiperidine and benzylpiperazine derivatives as novel reversible monoacylglycerol lipase (MAGL) inhibitors","volume":"263","author":"Di Stefano","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108698_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116285","article-title":"Discovery of a novel class of reversible monoacylglycerol lipase inhibitors for potential treatment of depression","volume":"268","author":"Hao","year":"2024","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108698_bb0200","doi-asserted-by":"crossref","first-page":"8039","DOI":"10.1038\/s41467-023-43606-3","article-title":"A monoacylglycerol lipase inhibitor showing therapeutic efficacy in mice without central side effects or dependence","volume":"14","author":"Jiang","year":"2023","journal-title":"Nat. Commun."},{"issue":"14","key":"10.1016\/j.bioorg.2025.108698_bb0205","doi-asserted-by":"crossref","first-page":"12331","DOI":"10.1021\/acs.jmedchem.4c01037","article-title":"Structure\u2013activity relationship studies of aryl sulfoxides as reversible monoacylglycerol lipase inhibitors","volume":"67","author":"Jiang","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108698_bb0210","article-title":"Monoacylglycerol lipase (MAGL)","volume":"EP3889132A1","author":"Granchi","year":"2021","journal-title":"Inhibitors"},{"issue":"13","key":"10.1016\/j.bioorg.2025.108698_bb0215","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1016\/j.bmc.2014.04.057","article-title":"Identification and characterization of a new reversible MAGL inhibitor","volume":"22","author":"Tuccinardi","year":"2014","journal-title":"Bioorg. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108698_bb0220","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0028-3908(90)90056-W","article-title":"Stereochemical effects of 11-OH-\u03948-tetrahydrocannabinol-dimethylheptyl to inhibit adenylate cyclase and bind to the cannabinoid receptor","volume":"29","author":"Howlett","year":"1990","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108698_bb0225","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1527-3458.2006.00021.x","article-title":"Pharmacological profile of the selective FAAH inhibitor KDS-4103 (URB597)","volume":"12","author":"Piomelli","year":"2006","journal-title":"CNS Drug Rev."},{"key":"10.1016\/j.bioorg.2025.108698_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102981","article-title":"Unraveling the parahormetic mechanism underlying the health-protecting effects of grapeseed procyanidins","volume":"69","author":"Baron","year":"2024","journal-title":"Redox Biol."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108698_bb0235","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1021\/acs.jmedchem.4c01778","article-title":"Novel Orthosteric\/allosteric ligands of cannabinoid receptors: an unexpected pharmacological profile","volume":"68","author":"Ferrisi","year":"2025","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2025.108698_bb0240","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1107\/S0907444902003451","article-title":"The Protein Data Bank","volume":"58","author":"Berman","year":"2002","journal-title":"Acta Crystall. Sect. D Biol. Crystallogr."},{"issue":"16","key":"10.1016\/j.bioorg.2025.108698_bb0245","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/jcc.20290","article-title":"The Amber biomolecular simulation programs","volume":"26","author":"Case","year":"2005","journal-title":"J. Comput. Chem."},{"issue":"16","key":"10.1016\/j.bioorg.2025.108698_bb0250","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bioorg.2025.108698_bb0255","series-title":"Published Online","author":"Maestro","year":"2016"},{"key":"10.1016\/j.bioorg.2025.108698_bb0260","series-title":"Published Online","author":"Macromodel","year":"2009"},{"issue":"6","key":"10.1016\/j.bioorg.2025.108698_bb0265","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.3109\/14756366.2015.1079184","article-title":"Identification of a new STAT3 dimerization inhibitor through a pharmacophore-based virtual screening approach","volume":"31","author":"Poli","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"7","key":"10.1016\/j.bioorg.2025.108698_bb0270","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1021\/ct400341p","article-title":"PTRAJ and CPPTRAJ: software for processing and analysis of molecular dynamics trajectory data","volume":"9","author":"Roe","year":"2013","journal-title":"J. Chem. Theory Comput."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108698_bb0275","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3390\/pharmaceutics15020453","article-title":"Biological evaluation and in vitro characterization of ADME profile of in-house Pyrazolo[3,4-d]pyrimidines as dual tyrosine kinase inhibitors active against glioblastoma Multiforme","volume":"15","author":"Poggialini","year":"2023","journal-title":"Pharmaceutics"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825005784?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825005784?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T05:05:40Z","timestamp":1776920740000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825005784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":55,"alternative-id":["S0045206825005784"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108698","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of reversible monoacylglycerol lipase (MAGL) inhibitors based on ortho-hydroxyanilide scaffold","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108698","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108698"}}